USMLE® Step 1 & 2

Kaplan USMLE Step 2: Managing a potassium abnormality

UPDATED . 6 MIN READ

If you’re preparing for the United States Medical Licensing Examination® (USMLE®) Step 2 exam, you might want to know which questions are most often missed by test-prep takers. Check out this example from Kaplan Medical, and read an expert explanation of the answer. Also check out all posts in this series.

Free study aid when you join the AMA

Medical students who become AMA members can select a free gift from a variety of powerful study aids for the USMLE and COMLEX-USA tests.

Supporting you today as a medical student. Protecting your future as a physician.

A 66-year-old man comes to the emergency department because of leg weakness and dyspnea. He has end-stage renal disease (ESRD) due to diabetic and hypertensive nephropathy and has been receiving chronic hemodialysis treatments for the past year. His medications include lisinopril and nifedipine. He has not adhered to prescribed dietary sodium and potassium restrictions and has missed his last two hemodialysis treatments.

His temperature is 37 °C (98.6 °F), pulse is 90 beats a minute, respiratory rate is 20 breaths per minute, and blood pressure is 186/82 mm Hg. The estimated jugular venous pressure is 12 cm H2O. There are bibasilar lung crackles, an S3 cardiac gallop sound, 1+ pitting pretibial edema, and decreased strength in both legs.

Laboratory studies show:

  • Hemoglobin: 8.8 g/dL.
  • Leukocyte count: 8,000/mm3.
  • Platelet count: 186,000/mm3.

Serum studies show:

  • Na+: 139 mEq/L.
  • Cl-: 100 mEq/L.
  • K+: 7.9 mEq/L.
  • HCO3-: 14 mEq/L.
  • Urea nitrogen (BUN): 156 mg/dL.
  • Creatinine: 7.2 mg/dL.
  • Glucose: 112 mg/dL.

ECG shows normal sinus rhythm with tall, tented/peaked T waves and a wide QRS complex. The patient receives one ampule of calcium gluconate, one ampule of 50% dextrose with 10 units of regular insulin, and an inhaled beta-2-adrenergic agonist.

Which of the following is the most appropriate next step in the management of the patient's potassium abnormality?

A. Administer 120 mg of furosemide IV.

B. Administer patiromer.

C. Emergent hemodialysis.

D. Send the patient home and arrange transportation for outpatient dialysis.

E. Stop lisinopril and monitor potassium levels.

 

 

 

 

 

 

 

 

 

 

 

 

The correct answer is C.

Severe hyperkalemia is defined by a serum potassium level above 6.5 mmol/L, ECG changes, or symptoms such as muscle cramping and needs to be addressed immediately.

Definitive potassium elimination with loop diuretics, sodium polystyrene or patiromer, or emergent hemodialysis, is required after protecting the cardiac membrane and temporarily redistributing potassium. Emergent hemodialysis is the best choice for this patient with ESRD and severe hyperkalemia.

Choice A: Administering 120 mg of furosemide IV may increase urinary potassium along with sodium excretion in someone who has preserved renal function. In the presence of end-stage renal disease, this will be much less effective.

 

Did you answer the question correctly?

Log in to get tips to remember and learn more from Kaplan Medical about why the other answer choices can be eliminated.

AMA membership has its advantages

  • Access education programs and study guides to help you thrive.
  • Distinguish yourself with AMA leadership opportunities.
  • Enjoy exclusive perks and savings.

Not a member? Become a member now.

FEATURED STORIES FOR MEDICAL STUDENTS